Trish Bromley
About Trish Bromley
Trish Bromley serves as the Global Group Director of Regulatory Affairs at Dechra Pharmaceuticals PLC, where she provides technical strategy on acquisitions and mergers. With extensive experience in regulatory affairs, she drives innovation in the animal health industry and oversees the development of regulatory strategies for various products.
Work at Dechra Pharmaceuticals
Trish Bromley serves as the Global Group Director of Regulatory Affairs at Dechra Pharmaceuticals PLC, a position she has held since 2020. In this role, she provides technical strategy on acquisitions and mergers and oversees the development and implementation of regulatory strategies for both new and existing products across various regions and markets. Her work emphasizes collaboration with internal and external stakeholders, including research and development, marketing, manufacturing, and regulatory authorities. Prior to her current role, she was the Director of Regulatory Affairs at Dechra Pharmaceuticals since 2019.
Current Role at Elanco
In addition to her responsibilities at Dechra Pharmaceuticals, Trish Bromley holds multiple roles at Elanco. She has been serving as an Advisor (Director) of Global Regulatory Innovation since 2015 and as a Senior Advisor (Director) of Global Regulatory: New Product Development since 2019. In these positions, she drives regulatory innovation and supports the development of new products, contributing to advancements in the animal health sector.
Education and Expertise
Trish Bromley has a strong educational background in veterinary medicine and surgery. She studied at the University of Glasgow from 1988 to 1993, where she achieved her BVMS MRCVS degree. Additionally, she attended King Edward VI, which further contributed to her foundational knowledge in the field. Her expertise lies in regulatory affairs, particularly in the animal health industry, where she focuses on delivering sustainable and effective solutions that enhance animal welfare.
Background
Trish Bromley's career spans several years in the regulatory affairs sector, with significant experience in both Dechra Pharmaceuticals and Elanco. She has been instrumental in driving innovation and change within the animal health industry. Her roles have involved facilitating cross-functional collaboration and alignment among various stakeholders, ensuring that regulatory strategies are effectively implemented to meet market needs.